# Role of Next-Generation Sequencing in Excluding the Nosocomial Origin of a Case of Legionnaires’ Disease Integrating Environmental Surveillance and Clinical Diagnosis

**Authors:** Francesco Paglione, Cataldo Maria Mannavola, Marilena La Sorda, Maria Luisa Ricci, Maria Scaturro, Silvia Laura Bosello, Roberta Masnata, Francesca Romana Monzo, Sara Vincenti, Patrizia Laurenti, Maurizio Sanguinetti, Flavio De Maio

PMC · DOI: 10.3390/microorganisms14020486 · 2026-02-17

## TL;DR

Next-generation sequencing helped determine that a Legionnaires' disease case was not caused by the hospital's water system, highlighting the importance of combining genomic tools with traditional methods.

## Contribution

Demonstrates the use of whole-genome sequencing to exclude a hospital as the source of Legionnaires' disease in a complex clinical scenario.

## Key findings

- Environmental isolates of Legionella were genetically identical but unrelated to the clinical isolate.
- Detection of Legionella anisa in the plumbing system revealed structural contamination.
- Integration of WGS with traditional methods improves surveillance accuracy and outbreak investigations.

## Abstract

Legionella pneumophila (Lp) remains one of the major causes of community- and hospital-acquired pneumonia, yet its diagnosis and source attribution continue to pose significant challenges. Here, we describe the case of an immunocompromised patient who developed Legionnaires’ disease during hospitalization. Following activation of the hospital’s internal surveillance system, Lp and Legionella anisa (L. anisa) were recovered from multiple water distribution points using a simplified culture-based protocol. Whole-genome sequencing (WGS) demonstrated that all environmental isolates belonged to a single clonal strain, whereas the clinical isolate was genetically unrelated, thereby excluding the hospital water system as the source of infection. Although not implicated in the patient’s disease, the detection of both Lp and L. anisa within the plumbing system highlighted underlying structural contamination and the potential masking effect of non-L. pneumophila species during culture-based surveillance. These findings support the integration of conventional microbiological methods with high-resolution genomic tools to enhance surveillance accuracy, support outbreak investigations, and strengthen public health responses. Overall, this case underscores the value of WGS as a decisive tool for source attribution, including the robust exclusion of a suspected nosocomial source, in complex clinical and environmental scenarios.

## Linked entities

- **Diseases:** Legionnaires’ disease (MONDO:0005824), pneumonia (MONDO:0005249)
- **Species:** Legionella pneumophila (taxon 446), Legionella anisa (taxon 28082)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CALCA (calcitonin related polypeptide alpha) [NCBI Gene 796] {aka CALC1, CGRP, CGRP-I, CGRP-alpha, CGRP1, CT}
- **Diseases:** infectious (MESH:D003141), rheumatoid nodules (MESH:D012218), septic (MESH:D001170), glaucoma (MESH:D005901), endocarditis (MESH:D004696), type 2 diabetes mellitus (MESH:D003924), infection (MESH:D007239), arterial hypertension (MESH:D000081029), bronchiectasis (MESH:D001987), encephalopathy (MESH:D001927), legionellosis (MESH:D007876), RA (MESH:D001172), LAC (MESH:C531622), pyelonephritis (MESH:D011704), cardiac strain (MESH:D013180), pneumonia (MESH:D011014), bacterial pneumonia (MESH:D018410), cytomegalovirus (CMV) viremia (MESH:D014766), cachexia (MESH:D002100), respiratory deterioration (MESH:D012131), septic bursitis (MESH:D002062), waterborne diseases (MESH:D000069578), lung diseases (MESH:D008171), multiorgan failure (MESH:D051437), Legionella infection (MESH:D007877), flu-like disease (MESH:D007251), impaired immunity (MESH:D020274), pulmonary involvement (MESH:C566343), necrotic acral ulcers (MESH:C000721267), inflammatory (MESH:D007249), vasculitis (MESH:D014657), pulmonary infections (MESH:D012141), injury to (MESH:D014947)
- **Chemicals:** creatinine (MESH:D003404), cefazolin (MESH:D002437), steroid (MESH:D013256), CO2 (MESH:D002245), linezolid (MESH:D000069349), macrolide (MESH:D018942), dexamethasone (MESH:D003907), glycerol (MESH:D005990), BCYE (-), blood glucose (MESH:D001786), methicillin (MESH:D008712), cefepime (MESH:D000077723), Water (MESH:D014867), agar (MESH:D000362), spectinomycin (MESH:D000198), azithromycin (MESH:D017963)
- **Species:** Legionella pneumophila (species) [taxon 446], Legionella anisa (species) [taxon 28082], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus aureus (species) [taxon 1280], Klebsiella oxytoca (species) [taxon 571], Staphylococcus capitis (species) [taxon 29388], Chryseobacterium shandongense (species) [taxon 1493872], Staphylococcus warneri (species) [taxon 1292], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Enterobacter cloacae complex (species group) [taxon 354276], Pseudomonas aeruginosa (species) [taxon 287], Brevundimonas diminuta (species) [taxon 293]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943603/full.md

---
Source: https://tomesphere.com/paper/PMC12943603